DarioHealth to Report Financial Results for the Third Quarter 2020 on November 12
DarioHealth Corp. (Nasdaq: DRIO) announced it will release its financial results for Q3 2020, ending September 30, on November 12, 2020. A conference call is scheduled for 9:00 AM Eastern Time to discuss the results, featuring key executives including CEO Erez Raphael. The call will allow investors to gain insights into the company's financial performance and future outlook within the digital therapeutics market. A replay of the call will be accessible for two weeks following the event.
- DarioHealth is recognized as a leading digital therapeutics company.
- The MyDario™ mobile app has a high user satisfaction rate.
- None.
NEW YORK, Nov. 4, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it would release its second quarter ended September 30, 2020, financial results on Thursday, November 12, 2020, and host a conference call at 9:00 am Eastern Time.
Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer will host the call.
Conference Call Details
Date: Thursday, November 12, 2020
Time: 9:00 am EDT
Toll-Free: 844-369-8770
International: 862-298-0840
Conference ID: DarioHealth Third Quarter 2020 Earnings Call and Webcast
Webcast: https://www.webcaster4.com/Webcast/Page/2224/38235
Participants are asked to dial in-10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through November 26, 2020. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 38235. The webcast replay will be available through February 12, 2021.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. By delivering evidence-based interventions driven by data, high-quality software, and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: https://www.dariohealth.com.
Logo - http://mma.prnewswire.com/media/544126/DarioHealth_Logo.jpg
DarioHealth Contact:
Claudia Levi
Content & Communications Manager
claudia@mydario.com
+1-347-767-4220
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390
View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-report-financial-results-for-the-third-quarter-2020-on-november-12-301166295.html
SOURCE DarioHealth Corp.
FAQ
When will DarioHealth report its Q3 2020 financial results?
What time is the DarioHealth conference call scheduled?
How can I access the DarioHealth earnings call replay?
Who will host the DarioHealth conference call?
What is DarioHealth's focus in the digital therapeutics market?
